A Phase 1/2 Study of the Angiogenesis Inhibitor Sorafenib in Cervical Cancer Patients Treated With Radiation Therapy

✍ Scribed by Chaudary, N.; Fyles, T.W.; Townsley, C.; Han, K.; Hill, R.P.; Kim, S.; Levin, W.; MacKay, H.; Manchul, L.; Yeung, I.; Oza, A.; Milosevic, M.

• Book ID: 126826934
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 77 KB
• Volume: 90
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2014.05.717